Guest guest Posted January 26, 2000 Report Share Posted January 26, 2000 Hello, Greetings from MindBrain. I would just once love to read an e mail that is just facts dealing with prostate cancer or for that fact, any cancer. You mention in your opening statement, that Vitamin C may, note the word may not be a good idea to take when undergoing chemo therapy. Then in the last paragraph, the statement says that more studies have to be done in order to see what tumor cells do with vitamin C...come on...lets help us people who have cancer... Mindbrain. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 26, 2000 Report Share Posted January 26, 2000 Sometimes, it's not wise to supplement when using Chemo. Consider the following. After reading this, I personally concluded that I would not advise on any nutrition to anyone undergoing chemo. Do your Chemo, then work like mad to get well. Remember that if you are using Chemo, that it's going to be more work to clean up the residual drugs and damage from the drugs. Chemo is not safe, or without complications. Be well, Date: Wed, 15 Sep 1999 21:29:43 -0500 From: Webster <michelle@...> Subject: [NH] Vitamin C May Interfere With Chemotherapy Of Cancer Tumors Vitamin C May Interfere With Chemotherapy Of Cancer Tumors Memorial Sloan-Kettering Cancer Center <http://www.mskcc.org> Contact: Joanne <publicaffairs@...> 212-639-3573 http://www.eurekalert.org/releases/mskc-cts091499.html 9-15-99 Cancer tumors shown to consume large amounts of vitamin C. Researchers are cautious about cancer patients taking vitamin C supplements . New York - Researchers at Memorial Sloan-Kettering Cancer Center have found that cancer tumors consume large amounts of vitamin C. Their findings, which are reported in the September 15 issue of Cancer Research, may shed new light on the nutritional needs of tumors. " This study is the first to demonstrate exactly how cancer cells acquire large quantities of vitamin C, " said Dr. Golde, senior author of the study and Physician-in-Chief of Memorial Hospital. Although the role that vitamin C plays in tumors is not yet known, recent studies have shown that there may be possible interactions between dietary antioxidants and chemotherapy treatment. Vitamin C is a powerful antioxidant that consumes free radicals - or toxic substances in the body that can also be generated from chemotherapy agents to destroy cancer cells. " It's possible that taking large amounts of vitamin C could interfere with the effects of chemotherapy or even radiation therapy, since these therapies often kill cells in part by using oxidative mechanisms. It's conceivable then, that vitamin C might make cancer treatment less effective and therefore, reasonable that cancer patients undergoing chemotherapy should avoid taking large amounts of this vitamin, " said Dr. Golde. Earlier research by Dr. Golde and his colleagues had established that specific glucose transporter molecules were responsible for transporting vitamin C into cells. This process ascorbic acid, is converted into the form of dehydroascorbic acid and transported into the cell. Once inside, the vitamin is converted back to ascorbic acid. This discovery prompted Dr. Golde's team to explore whether glucose transporter molecules and vitamin C might function in cancer cells, as malignant cells devour more glucose than normal cells to obtain the energy they need to grow. Subsequently, their laboratory studies with myeloid leukemia cells showed that the cells accumulated high levels of vitamin C through their glucose transporters. Building on this research, the researchers hypothesized that human leukemia, breast and prostate cancer cells would acquire large amounts of vitamin C in the same way. To find out, mice were injected with human cancer cells of the breast, prostate and blood and, after tumors had developed, were injected with ascorbic acid, dehydroascorbic acid, or sucrose (as a measure of blood volume). All tumors were subsequently analyzed for vitamin C content. The researchers found that the tumors readily took up vitamin C by a process involving the conversion of ascorbic acid to dehydroascorbic acid. " Now we know that tumors acquire and retain large amounts of vitamin C. So, it appears that tumors have nutritional needs, similar to other healthy cells that take in large amounts of the vitamin, " said Dr. Agus, first author of the study and an oncologist at Memorial Sloan-Kettering Cancer Center. " More studies need to be done to determine what the tumor cells do with the vitamin C once they get it. " ____________ Memorial Sloan-Kettering Cancer Center is the world's oldest and largest private institution devoted to prevention, patient care, research, and education in cancer. Throughout its long distinguished history, the Center has played a leadership role in defining the standard of care for patients with cancer. In 1999, Memorial Sloan-Kettering was named the nation's best cancer care center for the seventh consecutive year by U.S. News and World Report. Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 26, 2000 Report Share Posted January 26, 2000 Hello MindBrain, Her is somethin I think you will find interesting. INTERESTING. A PILOT SURVEY: STANDARD CANCER THERAPY COMBINED WITH NUTRACEUTICAL DIETARY SUPPLEMENTATION IMPROVES TREATMENT RESPONSES AND PATIENT QUALITY OF LIFE G.Hyl and, M.D.,D.,M.T, Medcenter One, Dept. Radiation Oncology, Bismarck, North Dakota. In thousands of cancer cases evaluated by H. , 87% of those with " spontaneous remissions " had made major dietary changes prior to tumor regression. The Dietary Supplement Health Education Act of 1994 resulted in millions of US citizens adding a plethora of supplements to their diets. A favorable response by 5 patients that failed all cancer therapy was noted after it was stopped. We found that they had consumed phytonutrient and phytogenin containing dietary supplements. A search revealed that Busbee et. al 1994 found a glyconutrient in these diet supplements increased IL-1,IL-6,INF andTNF production in monocyte cultures. See et. al 1999 reported enhanced NK lymphocyte cytolytic function in response to multiple glyconutrients. Barhomi et. al 1997 found glyconutriens increased intracellular reduced-glutathione protection 50% in liver cells. Such activity provides a potentioal differential effect for tumor cell destruction and normal cell protection. To increase our observations, patients with malignancies were solicited from a 3 state area and 127 volunteered to add nutraceuticals to their diet. 100 patients returned a quality of life survey focusing on weight loss, fatigue, nausea, vomiting, pain control, ability to complete treatments on schedule, physical activity and sense of well being. 40% of the group had failed standard therapy and were in a state of progressive disease. 60% were starting radiation or chemo-therapy. 85% reported improvements in the above clinical perameters. The phytogenin supplement contains plant sterols for nutrient based endocrine support. Ovarian, breast, uterine, and prostate malignancy patients werediscouraged from taking this nutrient. Some elected to add the phytogenin to their diet and they reported the best preservation of appetite, muscle mass, and had the least side-effects during treatment. Patients with a diagnoses of ovarian carcinoma, astrocytoma grade IV, lymphoma with mild marrow suppression, a massive pelvic myxosarcoma, and colon adenocarcinoma with brain metastasis had unprecendented responses. Conclusions: Nutraceutical dietary supplements (1) do not inhibit tumor cell destruction by radiation and chemotherapy (2) enhance tumor cell destruction (3) protect normal cells from radiation and cytotoxic damage (4) induce reductions in tumor mass in malignancies resistant to all treatments (5) improve quality of life for patients by reducing treatment toxicity and side effects from radiation and chemotherapy. A formal, controlled clinical study is warranted to further evaluate the effects of nutraceutical dietary supplementation in combination with standard cancer therapy. Fisher institute for Medical Research, P.O. Box 530689, Grand Prairie Texas 75053 E-mail helen@... (972) 660-3219 FAX (972) 660-1245 Quote Link to comment Share on other sites More sharing options...
Guest guest Posted January 26, 2000 Report Share Posted January 26, 2000 I didn't say a thing. I posted, in it's entirety, an article. Be well, At 06:02 PM 01/26/2000 EST, you wrote: >Hello, >Greetings from MindBrain. > >I would just once love to read an e mail that is just facts dealing with >prostate cancer or for that fact, any cancer. > >You mention in your opening statement, that Vitamin C may, note the word may >not be a good idea to take when undergoing chemo therapy. > >Then in the last paragraph, the statement says that more studies have to be >done in order to see what tumor cells do with vitamin C...come on...lets help >us people who have cancer... > >Mindbrain. > > >------------------------------------------------------------------------ >Visit http://cures for cancer.evangelist.net for cancer info or to unsubscribe > >------------------------------------------------------------------------ >Save 50% at MotherNature.com! See site for details. >1/766/5/_/378/_/948927740/ > >-- Create a poll/survey for your group! >-- vote?listname=cures for cancer & m=1 > > > Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.